Epha10-KO 基因敲除小鼠

1. Aasheim, Hans-Christian, Patzke, Sebastian, Hjorthaug, Hanne Sagsveen, Finne, Eivind Farmen. 2005. Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis. In Biochimica et biophysica acta, 1723, 1-7. doi:. https://pubmed.ncbi.nlm.nih.gov/15777695/

2. Zhao, Wenyue, Liu, Lu, Li, Xuehao, Xu, Shun. 2022. EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma. In International immunopharmacology, 110, 109031. doi:10.1016/j.intimp.2022.109031. https://pubmed.ncbi.nlm.nih.gov/35839564/

3. Xia, Haoran, Wang, Miaomiao, Su, Xiaonan, Guo, Xiaoxiao, Liu, Ming. 2022. A Novel Gene Signature Associated With "E2F Target" Pathway for Predicting the Prognosis of Prostate Cancer. In Frontiers in molecular biosciences, 9, 838654. doi:10.3389/fmolb.2022.838654. https://pubmed.ncbi.nlm.nih.gov/35495629/

4. Peng, Jing, Zhang, Danhua. 2021. Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration. In Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 69, 1215-1221. doi:10.1136/jim-2021-001836. https://pubmed.ncbi.nlm.nih.gov/33990369/

5. Huang, Sida, Ma, Lu, Liu, Xuezhong, Feng, Yong, Cai, Xinzhang. . A non-coding variant in 5' untranslated region drove up-regulation of pseudo-kinase EPHA10 and caused non-syndromic hearing loss in humans. In Human molecular genetics, 32, 720-731. doi:10.1093/hmg/ddac223. https://pubmed.ncbi.nlm.nih.gov/36048850/

6. Taki, Shintaro, Kamada, Haruhiko, Inoue, Masaki, Tsutsumi, Yasuo, Tsunoda, Shin-ichi. 2015. A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy. In PloS one, 10, e0144712. doi:10.1371/journal.pone.0144712. https://pubmed.ncbi.nlm.nih.gov/26678395/

7. Shin, Won-Sik, Park, Mi Kyung, Lee, Young Hun, Lee, Ho, Lee, Seung-Taek. 2020. The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells. In Cancer science, 111, 3292-3302. doi:10.1111/cas.14568. https://pubmed.ncbi.nlm.nih.gov/32644283/

8. Chen, Yu-Lin, Yen, Yi-Chen, Jang, Chuan-Wei, Chang, Jang-Yang, Chen, Ya-Wen. 2021. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells. In Scientific reports, 11, 644. doi:10.1038/s41598-020-80060-3. https://pubmed.ncbi.nlm.nih.gov/33436772/

9. Zang, Xinlong, Ding, Huaiwei, Zhao, Xiufeng, Deng, Yuihui, Zhao, Xiuli. 2016. Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA. In International journal of nanomedicine, 11, 3951-67. doi:10.2147/IJN.S107952. https://pubmed.ncbi.nlm.nih.gov/27574425/

10. Wang, Anqi, Zhu, Jianjie, Li, Yue, Huang, Jian-An, Liu, Zeyi. 2024. Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer. In Scientific reports, 14, 19623. doi:10.1038/s41598-024-70466-8. https://pubmed.ncbi.nlm.nih.gov/39179608/